Targeted Relief for GLP-1 Users: Formulated specifically to help reduce common side effects of GLP-1 medications like semaglutide and tirzepatide, including nausea, bloating, fatigue, and dehydration
If current usage of around three million adults rises closer to the additional two million who said they would like to start, even a modest increase in plan coverage could produce a sharp uptick in drug spend
Overall, long-acting GLP-1 receptor agonists were more effective in reducing weight than short-acting formulations
What these cups leave out is just as important: no frying, no dense grains, no strong flavors that might upset a sensitive stomach
Initially developed for glycemic control in diabetic patients, recent clinical findings have revealed their profound effects on weight loss, cardiovascular health, and metabolic regulation
This does not mean you cannot use both